In the article The who seem to be still relying on tamiflu even with the resistance profile - siting difficulty with absorbtion for patients with gastro/symptoms.and two mechanisms of resistance now
all the more reason to fast track production of iv relenza /lani- there has to be a tipping point in next 6 mths when who will be forced to stop whipping this dead dog and it's pup permirivir.
I wouldn't be surprised to see a lani deal announcement any day from now till sept. Just because bta mngmt have indicated behond 30 june doesn't mean it will unfold that way,
- Forums
- ASX - By Stock
- BTA
- new h5n1resistance
new h5n1resistance, page-5
Featured News
Add BTA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online